Problem statement: The main objective of the current study was investigation of the possible application of Gamma irradiation for treatment of the activated sludge generated wastewater treatment stations, to achieve the standard requirements in term of pathogens content. Approach: Activated sludge samples were collected from Riyadh wastewater plant and analyzed quantitatively for the presence of important bacterial parameters including fecal coliforms and Salmonella spp. The collected samples were treated with various doses of Gamma irradiation and bacterial count was determined. Results: The results indicated that all tested sludge samples were positive for the presence of fecal coliforms and Salmonella spp, with different counts in different stages of wastewater treatment. The raw sludge showed to have the highest coliforms and Salmonella spp counts of 1.1×108 and 2×103 MPN g-1 dry sludge, respectively. Furthermore, coliforms and Salmonella spp were detected in final resulted sludge with count of 2.5×107 and 6×102 MPN g-1 dry sludge, respectively. It was found that treatment of samples with gamma irradiation was able to reduce the fecal coliforms and Salmonella spp effectively and the reduction efficiency was increased by increasing the irradiation dose. Fecal coliforms and Salmonella counts were reduced to less than 100 MPN g-1 dry sludge by exposing to 1.5 and 0.25 kGy respectively. Furthermore, Gamma radiation dose of 2.0 kGy was able to remove both fecal coliforms and Salomnella spp completely. In addition, D10 values were determined and was found to be 0.25 and 0.24 kGy for fecal coliforms and Salmonella spp., respectively. Conclusion/Recommendations: The results indicating that the resulted activated sludge generated from Riyadh wastewater plant are rich with important pathogens and therefore further treatment procedures are necessary to achieve the required standards, before any land application. Application of Gamma irradiation in treatment of the activated sludge showed to be a promising safe technology for this purpose
Natural products have been an important historical source of therapeutic agents. Microorganisms are major source of bioactive natural products, and several microbial products including antibiotics, antiinflammatory, anti-tumour, immunosuppressants and others are currently used as therapeutic agents for human and domestic animals. Most of these products were obtained from cultured environmental microorganisms. However, it is widely accepted that a very large majority of the microorganisms present in natural environments are not readily cultured under laboratory conditions, and therefore are not accessible for drug discovery. Metagenomics is a recent culture-independent approach that has been developed to access the collective genomes of natural bacterial populations. It enables discovery of the diverse biosynthetic pathways encoded by diverse microbial assemblages that are known to be present in the environment but not-yet cultured. Recently, several new bioactive molecules and proteins have been discovered using a metagenomic approach. This review highlights the recent methodologies, limitations, and applications of metagenomics for the discovery of new drugs. Moreover, it shows how a multidisciplinary approach combining metagenomics with other technologies can expedite and revolutionize drug discovery from diverse environmental microorganisms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.